Health Care Products and Services

We provide economic analysis, expert testimony, and regulatory insight to support all phases of litigation pertaining to the health care industry.

Rising health care costs and growing concern over access to health care has created an environment in which producers of health care products and services face increased scrutiny of their business practices and pricing decisions. At the same time, contractual arrangements among industry participants are growing increasingly complex, and the patents that have been so important in the development of these industries face a wide array of challenges.

Economists at The Brattle Group have decades of experience working on cases involving every type of participant in these industries, including pharmaceutical manufacturers, medical device suppliers, insurers, government regulators, hospitals, physicians, pharmacy benefit managers, and others.

Brattle provides its clients with rigorous analysis while managing costs carefully in order to deliver the maximum net value to our clients. We are known for our close working relationships with leading academics and practitioners and for the clear and successful communication of economic and financial reasoning to clients, judges, juries, and other decision makers.

Areas of Expertise
Abere 068
Dr. Abere provides economic research, data analysis, and expert witness testimony in cases involving antitrust, contracts, intellectual property, and other commercial litigation as well as regulatory proceedings. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Borucki 113
Ms. Borucki is a financial economist with experience providing advice and developing expert testimony on the application of corporate finance and economics in both litigation and strategic engagements. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Cameron 063
Dr. Lisa Cameron is an economist with two decades of experience consulting to attorneys and companies involved in commercial litigation, regulatory proceedings, and other complex matters. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Professor McFadden is a winner of the 2000 Nobel Prize in Economics, the E. Morris Cox Professor Emeritus of Economics at the University of California at Berkeley, and the founding director of its Econometrics Laboratory. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Neels 241
Dr. Neels has more than 30 years of research and consulting experience in all aspects of the transportation sector. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Dr. Reynolds is widely known for his empirical and theoretical analyses of antitrust, regulatory, and financial issues. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Academic Advisors
Academic Advisor
Dr. Bowblis is an Associate Professor in the Department of Economics at Miami University, where he teaches courses in health economics, antitrust, industrial organization, econometrics, and the economics of regulation. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Academic Advisor
Dr. Grabowski is a Professor of Economics, member of the faculty for the Health Sector Management Program, and Director of the Program in Pharmaceuticals and Health Economics at Duke University. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
Academic Advisor
Dr. Philipson is a Professor of Public Policy Studies at the Irving B. Harris Graduate School of Public Policy Studies at The University of Chicago, where he teaches courses in microeconomics and health economics. More icon f02782c24cccaf6d90e1da53920c42f20e5a8955f54ac2ca5727ec7dc89987b4
An Empirical Approach To Reverse Payment Settlements
July 6, 2015
Published on Law360
Antitrust Analysis in Physician, Hospital, and Insurer Matters
An empirical analysis of the multimarket contact theory in pharmaceutical markets
July 2013
Pedro L. Marin, Javier Coronado, and Sergi Jimenez-Martin
Published in The European Journal of Health Economics
Preliminary Injunctions in Pharmaceutical Litigation: The Economics of Irreparable Harm
February 2011
Published by The Brattle Group, Inc.